By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Key Statistics

Ownership: Public

Web Site: Gilead Sciences, Inc.
Employees: 4,000
Symbol: GILD


Company News
Envisionrx And Gilead Sciences, Inc. (GILD) Sign Exclusive Agreement To Help In The Fight Against Hepatitis C 1/26/2015 1:28:38 PM
Mylan Inc. (MYL) Expands Hepatitis C Licensing Agreement With Gilead Sciences, Inc. (GILD) To Include Investigational Pan-Genotypic Agent 1/26/2015 10:28:20 AM
Gilead Sciences, Inc. (GILD) to Allow Generic Drugmakers to Produce New Hep C Drug 1/26/2015 6:30:29 AM
After Gilead Sciences, Inc. (GILD)-AbbVie (ABBV)'s Hep C Price War, Express Scripts Inc. Eyes Cancer Meds Next 1/23/2015 6:40:49 AM
Investment Firm Names Gilead Sciences, Inc. (GILD)'s Martin CEO Of 2014 1/23/2015 6:25:39 AM
Strides Arcolab Limited Snags Huge HIV Pact With Gilead Sciences, Inc. (GILD) 1/20/2015 6:30:55 AM
SoCal's Kite Pharma, Inc. (KITE) Talks With Insurers to Avoid Gilead Sciences, Inc. (GILD) Price War 1/15/2015 4:15:18 PM
Gilead Sciences, Inc. (GILD)'s India Patent Roadblock May Spur More Sovaldi Copies 1/15/2015 6:27:34 AM
J.P. Morgan: Gilead Sciences, Inc. (GILD) President Says 48% of Revenue Comes From Hep C Drugs 1/13/2015 3:55:03 PM
Gilead Sciences, Inc. (GILD) To Present At The 33rd Annual J.P. Morgan Healthcare Conference On Tuesday, January 13 1/13/2015 10:30:42 AM